Controlling the intracellular fate of nano-bioconjugates: pathways for realizing nanoparticle-mediated theranostics

For nanomaterials to realize their full potential in disease diagnosis and drug delivery applications, one must be able to exert fine control over their cellular delivery, localization and long-term fate in biological systems. Our laboratory has been active in developing methodologies for the controlled and site-specific delivery of a range of nanomaterials (e.g., quantum dots, colloidal gold, nematic liquid crystals) for cellular labeling, imaging and sensing. This talk will highlight several examples from these efforts and will demonstrate the use of peptide- and protein-mediated facilitated delivery of nanomaterials to discrete cellular locations including the endocytic pathway, the plasma membrane and the cellular cytosol. The implications of the ability to exert fine control over nanomaterial constructs in biological settings will be discussed with a particular focus on their use in nanoparticle-based theranostics.

[1]  Michael J Sailor,et al.  Hybrid Nanoparticles for Detection and Treatment of Cancer , 2012, Advanced materials.

[2]  John Archdeacon,et al.  A non-covalent peptide-based carrier for in vivo delivery of DNA mimics , 2007, Nucleic acids research.

[3]  R. Deschenes,et al.  Palmitoylation: policing protein stability and traffic , 2007, Nature Reviews Molecular Cell Biology.

[4]  Igor L. Medintz,et al.  Delivering quantum dot-peptide bioconjugates to the cellular cytosol: escaping from the endolysosomal system. , 2010, Integrative biology : quantitative biosciences from nano to macro.

[5]  加藤 伸吾.  Organ distribution of quantum dots after intraperitoneal administration, with special reference to area-specific distribution in the brain , 2011 .

[6]  J. Matthew Mauro,et al.  Long-term multiple color imaging of live cells using quantum dot bioconjugates , 2003, Nature Biotechnology.

[7]  P. Dawson,et al.  Palmitoyl:protein thioesterase (PPT1) inhibitors can act as pharmacological chaperones in infantile Batten disease. , 2010, Biochemical and biophysical research communications.

[8]  Vincent Noireaux,et al.  In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles , 2002, Science.

[9]  Igor L. Medintz,et al.  Kinetics of metal-affinity driven self-assembly between proteins or peptides and CdSe-ZnS quantum dots , 2007 .

[10]  Igor L. Medintz,et al.  Monitoring of enzymatic proteolysis on a electroluminescent-CCD microchip platform using quantum dot-peptide substrates , 2009 .

[11]  Igor L. Medintz,et al.  Peptides for specific intracellular delivery and targeting of nanoparticles: implications for developing nanoparticle-mediated drug delivery. , 2010, Therapeutic delivery.

[12]  Sangeeta N. Bhatia,et al.  Intracellular Delivery of Quantum Dots for Live Cell Labeling and Organelle Tracking , 2004 .

[13]  Masato Yasuhara,et al.  Quantum Dots Targeted to the Assigned Organelle in Living Cells , 2004, Microbiology and immunology.

[14]  Igor L. Medintz,et al.  Selecting improved peptidyl motifs for cytosolic delivery of disparate protein and nanoparticle materials. , 2013, ACS nano.

[15]  I. Rodrı́guez-Crespo,et al.  Protein palmitoylation and subcellular trafficking. , 2011, Biochimica et biophysica acta.